A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive

PHASE1CompletedINTERVENTIONAL
Enrollment

651

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

July 18, 2024

Study Completion Date

July 18, 2024

Conditions
Respiratory Syncytial Virus
Interventions
BIOLOGICAL

mRNA-1345

Formulation for injection

DRUG

Placebo

0.9% sodium chloride (normal saline) injection

Trial Locations (31)

29204

Velocity Clinical Research - Columbia - PPDS, Columbia

40517

Michael W. Simon, M.D., PSC, Nicholasville

48202

Henry Ford Health System, Detroit

61614

Synexus - Optimal Research - Peoria, Peoria

68134

Velocity Clinical Research (Omaha - Nebraska) - PPDS, Omaha

68701

Velocity Clinical Research (Norfolk - Nebraska) - PPDS, Norfolk

68803

Velocity Clinical Research (Grand Island - Nebraska) - PPDS, Grand Island

68901

Velocity Clinical Research (Hastings - Nebraska) - PPDS, Hastings

70006

Velocity Clinical Research (Metaire - Louisiana) - PPDS, Metairie

77065

Cyfair Clinical Research Center - ERN - PPDS, Houston

84041

Tanner Clinic, Layton

90046

Mills Clinical Research, West Hollywood

91942-3189

Paradigm Clinical Research Institute Inc - ClinEdge - PPDS, La Mesa

32720-0834

Accel Research Site - Angel Kids Pediatrics - ERN - PPDS, DeLand

32806-2908

Accel Research Sites - Nona Pediatric Center - ERN - PPDS, Orlando

33409-3401

Palm Beach Research - ClinEdge - PPDS, West Palm Beach

31904-8946

Centricity Research - Roswell - HyperCore - PPDS, Columbus

30030-3438

IResearch Atlanta LLC, Decatur

31406-2675

Velocity Clinical Research (Savannah - Georgia) - PPDS, Savannah

96814-4526

East-West Medical Research Institute, Honolulu

51106-4233

Velocity Clinical Research (Sioux City - Iowa) - PPDS, Sioux City

70508-5173

Velocity Clinical Research (Lafayette - Louisiana) - PPDS, Lafayette

70458-5334

Velocity Clinical Research (Slidell - Louisiana) - PPDS, Slidell

64114-4866

Alliance for Multispecialty Research - Kansas City, Kansas City

87102-3876

Velocity Clinical Research (Albuquerque - New Mexico) - PPDS, Albuquerque

13901-1046

Velocity Clinical Research (Binghamton - New York) - PPDS, Binghamton

97504-9741

Velocity Clinical Research - Medford - ERN - PPDS, Medford

29615-4833

Velocity Clinical Research (Greenville - South Carolina) - PPDS, Greenville

78229-3539

Flourish Research - San Antonio - PPDS, San Antonio

77375-6543

DM Clinical Research, Tomball

23226-3787

Clinical Research Partners LLC, Richmond

All Listed Sponsors
lead

ModernaTX, Inc.

INDUSTRY

NCT04528719 - A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive | Biotech Hunter | Biotech Hunter